Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study
- 3 December 2025
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 173 (2) , 1045-1052
Abstract
Objective: To evaluate serum magnesium concentrations in pregnant women with severe pre‐eclampsia being treated with a novel magnesium sulfate regimen for seizure prevention. Methods: This was a prospective, longitudinal study. Pregnant women aged 18 years or older with severe pre‐eclampsia and an indication for treatment with magnesium sulfate were included. Participants received a magnesium sulfate loading dose of 4.5 g over 20 min, then a maintenance dose of 1.5 g/h (the standard regimen at the study center). Serum magnesium concentrations were measured at admission, 30 min, 1, 2, 4, and 6 h, then every 6 h until treatment was stopped. Median (interquartile range [IQR]) serum magnesium concentrations are reported. The primary outcome was serum magnesium concentrations during magnesium sulfate infusion. Results: Serum magnesium concentrations at admission and after 30 min were 0.77 (IQR 0.72–0.82) and 1.81 (IQR 1.63–1.97) mmol/L, respectively. After 4 h, the concentration had decreased slightly to 1.79 (IQR 1.58–2.02) mmol/L. By 12 h, magnesium levels had stabilized at 2 mmol/L. At this time, 50.9% (28/55) had achieved therapeutic magnesium levels (2.0–3.5 mmol/L), and this proportion had increased to 61.7% (29/47) by 24 h. Magnesium toxicity was observed in three patients (4.7%). No cases of eclampsia or maternal mortality were recorded. Conclusions: This magnesium sulfate regimen was generally well tolerated and also prevented seizures even though serum magnesium levels at 24 h were below the currently defined therapeutic range in at least one‐third of participants.Keywords
This publication has 36 references indexed in Scilit:
- Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal NeuroprotectionObstetrics and Gynecology Clinics of North America, 2023
- Eclampsia despite magnesium sulfate prophylaxisAmerican Journal of Obstetrics and Gynecology, 2023
- Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsiaAJOG Global Reports, 2021
- Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated FactorsDrugs in R&D, 2020
- Pharmacokinetics and placental transfer of magnesium sulfate in pregnant womenAmerican Journal of Obstetrics and Gynecology, 2016
- Pre-eclampsiaThe Lancet, 2016
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialThe Lancet, 2002
- Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia TrialThe Lancet, 1995
- A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1984
- Problems encountered in the treatment of pregnancy-induced hypertensionAmerican Journal of Obstetrics and Gynecology, 1978